Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.26 - $0.64 $786,173 - $1.94 Million
-3,023,745 Reduced 78.95%
806,171 $210,000
Q1 2022

May 16, 2022

BUY
$0.52 - $1.0 $47,736 - $91,800
91,800 Added 2.46%
3,829,916 $2.3 Million
Q4 2021

Feb 14, 2022

BUY
$0.85 - $1.33 $216,715 - $339,095
254,959 Added 7.32%
3,738,116 $3.66 Million
Q3 2021

Nov 15, 2021

BUY
$1.03 - $1.41 $521,544 - $713,959
506,354 Added 17.01%
3,483,157 $4.53 Million
Q2 2021

Aug 16, 2021

BUY
$1.04 - $1.5 $3.1 Million - $4.47 Million
2,976,803 New
2,976,803 $3.27 Million

Others Institutions Holding NMTR

About 9 METERS BIOPHARMA, INC.


  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.